This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about RNA-binding protein 39.
. .
Human | |
---|---|
Gene Name: | RBM39 |
Uniprot: | Q14498 |
Entrez: | 9584 |
Belongs to: |
---|
splicing factor SR family |
CAPER; CC1.3; coactivator of activating protein-1 and estrogen receptors; DKFZp781C0423; FLJ44170; fSAP59; functional spliceosome-associated protein 59; HCC1CAPERalpha; Hepatocellular carcinoma protein 1; RNA binding motif protein 39; RNA-binding motif protein 39; RNA-binding protein 39; RNA-binding region-containing protein 2; RNPC2; RRM) containing 2; splicing factor CC1.3; Splicing factor HCC1
Mass (kDA):
59.38 kDA
Human | |
---|---|
Location: | 20q11.22 |
Sequence: | 20; NC_000020.11 (35701347..35742336, complement) |
Widely expressed. Highly expressed in pancreas, skeletal muscle, lung and brain. Expressed at intermediate level in kidney, liver and heart.
Nucleus speckle. Concentrated in nuclear speckles. Colocalizes with the core spliceosomal snRNP proteins.
High-affinity primaries antibodies are essential for many purposes, including antibody preparation. Boster offers antibodies with high affinity and good citation numbers. These antibodies have been confirmed in immunohistochemistry or Western Blotting making them a reliable option. This article will discuss the main points of Steven Boster’s life and his work.
Boster bio high-affinity prima antibodies against RBG39 marker allow scientists to target this tumor-specific protein more precisely. This marker is found in many cancers, such as adrenocortical, cervical squamous, colorectal, colorectal, diffuse large-cell lymphoma (DLB), glioblastoma multiforme and pancreatic cancer.
The RBM39 gene, in addition to being a versatile marker for DNA detection, may also play an important part in many cellular processes. For instance, the gene controls alternative splicing of RNA molecules. By regulating the levels of transcripts, the RBM39 gene may regulate the expression of many different proteins. Below are highlights of Steven Boster’s career using the RBM39 gene marker.
PMID: 8227358 by Imai H., et al. Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma.
PMID: 15798186 by Cazalla D., et al. A novel SR-related protein is required for the second step of pre- mRNA splicing.